NAFANUA BRAGINSKY: Open Payments
NPI 1346339264 · HONOLULU, HI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,413 in 52 payments from 10 companies in 2025. Trend: 2023 $329 · 2024 $896 · 2025 $1,413
Food & beverage: $1,413
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $419 |
| Janssen Biotech, Inc. | 16 | $383 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $184 |
| PFIZER INC. | 7 | $120 |
| Madrigal Pharmaceuticals | 3 | $88 |
| GENZYME CORPORATION | 2 | $73 |
| Regeneron Healthcare Solutions, Inc. | 2 | $46 |
| Celltrion USA Inc. | 2 | $43 |
| Ardelyx, Inc. | 1 | $33 |
| Exact Sciences Corporation | 1 | $23 |
Products named: TREMFYA, SKYRIZI, RINVOQ, ENTYVIO, DUPIXENT, REZDIFFRA, XELJANZ, VEGZELMA.
Industry payments across HI — which companies pay providers there.
